Engineers Gate Manager LP Eagle Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $64,458 - $211,753	13,922 New	13,922 $72,000
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $183,524 - $228,404	4,448 Added 83.62%	9,767 $434,000
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $237,121 - $279,779	5,319 New	5,319 $263,000
Q3 2021 Nov 15, 2021	SELL	$43.79 - $55.78 $439,388 - $559,696	-10,034 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $269,594 - $325,473	-7,314 Reduced 42.16%	10,034 $429,000
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $22,740 - $28,747	564 Added 3.36%	17,348 $724,000
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $456,166 - $561,351	-10,934 Reduced 39.45%	16,784 $782,000
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $238,186 - $329,935	6,434 Added 30.23%	27,718 $1.18 Million
Q2 2020 Aug 17, 2020	SELL	$43.24 - $55.02 $367,583 - $467,725	-8,501 Reduced 28.54%	21,284 $1.02 Million
Q1 2020 May 15, 2020	BUY	$34.37 - $60.07 $702,007 - $1.23 Million	20,425 Added 218.22%	29,785 $1.37 Million
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $590,132 - $698,663	-10,864 Reduced 53.72%	9,360 $562,000
Q3 2019 Nov 14, 2019	BUY	$53.25 - $59.98 $1.08 Million - $1.21 Million	20,224 New	20,224 $1.14 Million
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $1.09 Million - $1.37 Million	-23,459 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $335,607 - $449,849	-8,681 Reduced 27.01%	23,459 $1.18 Million
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $269,708 - $497,476	7,345 Added 29.62%	32,140 $1.3 Million
Q3 2018 Nov 01, 2018	BUY	$66.65 - $83.86 $57,319 - $72,119	860 Added 3.59%	24,795 $1.72 Million
Q2 2018 Aug 03, 2018	BUY	$51.25 - $76.62 $1.23 Million - $1.83 Million	23,935 New	23,935 $1.81 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account